HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Brachyolmia Type 3

Also Known As:

Brachyolmia, Autosomal Dominant; Brachyrachia

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Bone Diseases: 5863
  - Developmental Bone Diseases: 153
    - Osteochondrodysplasias: 592
      - Brachyolmia Type 3: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Osteochondrodysplasias: 592
    - Brachyolmia Type 3: 1

Experts

1.	Geiberger, Stefan: 1 article (07/2014)
2.	Grigelioniene, Giedre: 1 article (07/2014)
3.	Horemuzova, Eva: 1 article (07/2014)
4.	Jäntti, Nina: 1 article (07/2014)
5.	Moström, Eva: 1 article (07/2014)
6.	Mäkitie, Outi: 1 article (07/2014)
7.	Neumeyer, Lo: 1 article (07/2014)
8.	Nordenskjöld, Magnus: 1 article (07/2014)
9.	Nordgren, Ann: 1 article (07/2014)
10.	Åström, Eva: 1 article (07/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Brachyolmia Type 3:

1.	Transient Receptor Potential ChannelsIBA 07/01/2014 - "Autosomal dominant brachyolmia (Type 3, OMIM #113500) belongs to a group of skeletal dysplasias caused by mutations in the transient receptor potential cation channel, subfamily V, member 4 (TRPV4) gene, encoding a Ca++-permeable, non-selective cation channel. "
2.	CationsIBA 07/01/2014 - "Autosomal dominant brachyolmia (Type 3, OMIM #113500) belongs to a group of skeletal dysplasias caused by mutations in the transient receptor potential cation channel, subfamily V, member 4 (TRPV4) gene, encoding a Ca++-permeable, non-selective cation channel. "